Substitution, in part or totally, of the β-receptor antagonist, oxprenolol, for clonidine in 187 hypertensive patients resulted in significant reduction in blood pressure levels, particularly of systolic pressure.
The incidence of unwanted side-effects was markedly reduced, with an accompanying improvement in the quality of the patient's life.
Get full access to this article
View all access options for this article.
References
1.
BreckenridgeADolleryCTPerryEHO (1970) Prognosis of treated hypertension. Quarterly Journal of Medicine39, 411
2.
BulpittCJDolleryCT (1973) Side-effects of hypotensive agents evaluated by a self administered questionnaire. British Medical Journal3, 485
3.
ForrestWA (1974) Hypertension—its nature and treatment. p 245, Ciba, Malta
4.
HökfeltBHedelandHDymlingJF (1970) Studies on catecholamines, renin and aldosterone following Catapres®; in hypertensive patients. European Journal of Pharmacology10, 389
5.
HunyorSNHanssonLHamsonTSHookerSW (1973) Effects of clonidine withdrawal: Possible mechanisms and suggestions for management. British Medical Journal2, 209
6.
LeishmanAWD (1963) Merits of reducing high blood pressure. Lancet1, 1284
7.
PearsonRMBulpittCGeorgeCFHoleDBreckenridgeA (1974) Guanethidine and oxprenolol in hypertension. Scottish Medical Journal19, 45
8.
Veterans Administrative Co-operative Study Group on Antihypertensive Agents (1967) I Effects of treatment on morbidity in hypertension: Results in patients with diastolic blood pressures averaging 115 through 129 mmHg. Journal of the American Medical Association202, 1028
9.
Ibid (1970) II Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. Journal of the American Medical Association213, 1143
